# Foam Au driven by 4$ω$ - 2$ω$ ignition laser pulse for inertial confinement fusion

Article · Ke Lan, Peng Song

- Archive id: arxiv:1704.00178
- Published: 2017-04-01
- Venue: Physics of Plasmas
- DOI: https://doi.org/10.1063/1.4983329
- arXiv: https://arxiv.org/abs/1704.00178
- Citations: 11
- Source URL: https://arxiv.org/abs/1704.00178
- PDF: https://arxiv.org/pdf/1704.00178
- Provenance: arxiv

## Abstract

Green light (2$ω$) has the potential to drive ignition target for laser fusion with significantly more energy than blue light (3$ω$) and a relatively higher damage threshold for the optic components in the final optic assembly, but it has issues of a relatively low laser to x-ray conversion efficiency and a hard x-ray spectrum as compared to 3$ω$. In this paper, we propose to drive a foam hohlraum wall with an ignition laser pulse by taking a 4$ω$ laser at the pre-pulse and a 2$ω$ laser at the main-pulse, called as 4$ω$ - 2$ω$ ignition pulse. This novel design has the following advantages: (1) benefiting from 2$ω$ of its relatively high energy output and low damage threshold during main-pulse, (2) benefiting from foam in its relatively high laser to x-ray conversion efficiency and relatively low M-band fraction in re-emission, (3) benefiting from 4$ω$ of its low LPI during pre-pulse. From our 1D simulations with Au material, the laser to x-ray conversion in a foam driven by 4$ω$ - 2$ω$ pulse has an increase of $28\\%$ as compared to a solid target driven by 3$ω$ with the same pulse shape. The relatively thin optical depth of foam is one of the main reasons for the increase of laser to x-ray conversion efficiency inside a foam target.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Inertial Confinement Fusion](https://space-kitty.com/topics/inertial-fusion)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.